Professional
Added to YB: 2024-03-11
Pitch date: 2024-03-07
SILK [bullish]
Silk Road Medical, Inc
+69.07%
current return
Author Info
No bio for this author
Company Info
Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR).
Market Cap
$1.1B
Pitch Price
$16.26
Price Target
24.00 (-13%)
Dividend
N/A
EV/EBITDA
-17.89
P/E
-19.06
EV/Sales
5.38
Sector
Health Care Equipment and Supplies
Category
growth
Silk Road Medical, Inc: Upgrading to BUY with a target of $24 Bullish
SILK: Argus upgrades to BUY, PT $24. Expanding US sales force & entering China/Japan markets. TCAR procedure for CAD underpenetrated; only 25.2k US procedures in '23. Upside in $1.2B US & $2.3B overseas markets undiagnosed/treated. Q4'23 solid, -0.33 EPS beating consensus, 18% rev growth, 73.6% GM. 2024 focus on profitable growth, 10-12% revenue growth, better margins. Financials stable with $20.2M cash, $161.3M short-term investments. Risks: Small-cap volatility, manufacturing, CMS reimbursement.
Read full article (5 min)